Advances in LC/MS for the Characterization of Biotherapeutics

Authors

  • Jonathan L. Josephs Genentech, South San Francisco, California, USA
 https://orcid.org/0000-0002-0620-8086
  • Aaron Bailey University of Texas Medical Branch, Galveston, Texas, USA
  • Stephane Houel Thermo Fisher Scientific, San Jose, California, USA

DOI:

https://doi.org/10.33892/aph.2021.91.152-153

Keywords:

Orbitrap, HRAM, native MS, middle down, intact protein

Published

2021-11-15

How to Cite

(1)
Josephs, J. L.; Bailey, A.; Houel, S. Advances in LC/MS for the Characterization of Biotherapeutics. Acta Pharm Hung 2021, 91, 152-153.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License